The new drug prevents RSV lower respiratory tract disease in infants and children entering or during their first RSV season and is the second monoclonal antibody on the market.
, is the first of its kind likely to be widely available to everyone up to 24 months of age beyond a small population of immunocompromised children.
The other option –FDA officials approved the drug basedshowing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger. Although the drug is not a vaccine, it is meant to prevent severe illness like a vaccine.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA approves antibody to protect infants from RSV | CNNParents and pediatricians will have a new option this fall to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year of age in the United States every year.
Les mer »
FDA approves new drug to protect babies from RSVThe FDA approved a new drug to protect babies from RSV, the leading cause of hospitalization for U.S. infants.
Les mer »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Les mer »
FDA approves antibody shot to protect infants from potentially deadly virus RSVThis injection was approved to protect against the annual leading cause of hospitalization in infants under a year old in the U.S.
Les mer »
FDA approves antibody shot to protect infants from potentially deadly virus RSVThis injection was approved to protect against the annual leading cause of hospitalization in infants under a year old in the U.S.
Les mer »
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonLast year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
Les mer »